Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LMWH for Pregnancy Outcomes in Protein S Deficiency
NCT06531525Phase 2Not yet recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Aug 2024
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of enoxaparin in protein S deficiency (3 arms), sponsored by Peking University People's Hospital. Primary endpoint: Rate of livebirth up to 42 months. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
enoxaparin
03
Conditions
protein S deficiency
Beyond the preview
Go deeper on NCT06531525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06531525.